Nightmare Disorder
On this page
Direct answer
Late-night, vividly remembered, fear-laden dreams that jolt the sleeper awake with orientation and recall intact define nightmare disorder — a REM parasomnia whose timing (second half of the night, when REM density peaks) is diagnostic in itself. The differential is arithmetic at the bedside: sleep terrors occur in the first third of the night in deep NREM sleep, produce screaming with tachycardia, confusion and amnesia for the event, while nightmares are remembered in detail; REM sleep behaviour disorder produces acted-out dreams with physical injuries, usually in older men, and is a prodrome of synucleinopathic neurodegeneration. First-line treatment is imagery rehearsal therapy — rewriting the nightmare's script and rehearsing the new version daily — with prazosin as the pharmacological option for trauma-related nightmares, though evidence has grown mixed.
What you must remember
- DSM-5 core: repeated extended, dysphoric, well-remembered dreams (usually threatening survival, security or esteem), occurring in the second half of the night; rapid orientation on waking; clinically significant distress or impairment.
- Timing logic: nightmares ride REM sleep — late night; terrors ride N3 — early night; this single axis separates the classic pairs.
- Secondary causes to screen: withdrawal of REM-suppressing agents (alcohol, antidepressants, beta-blockers stopped abruptly cause REM rebound nightmares), PTSD (nightmares are a core criterion C symptom), fever, obstructive sleep apnoea (treating apnoea reduces nightmares), and dopaminergic drugs.
- First-line treatment: imagery rehearsal therapy (IRT) — rescript the nightmare into any chosen alternative ending and rehearse the rewritten dream 10-20 minutes daily; robust trial support including in PTSD.
- Prazosin: 1 mg nocte titrated toward 5-10 mg for trauma-related nightmares; widely used, but evidence is mixed since the negative 2018 PACT randomised trial — present both facts.
- The RBD red flags: dream enactment with injuries, older male, video-polysomnographic loss of REM atonia — think synucleinopathy prodrome (Parkinson disease, Lewy body dementia) and treat with melatonin or clonazepam.
- Do not default to hypnotics: suppressive agents risk REM rebound on withdrawal — the prescribing loop that feeds the disorder.
Treating the dream, not the night
A 30-year-old teacher wakes three nights a week at 3 am from dreams of a bus accident, drenched, heart pounding, able to describe every detail to the frightened partner beside her. The clinical pathway starts with a month of sleep-wake history: confirm late-night timing and intact orientation, exclude sleep apnoea (her snoring earns a study), take a trauma history (there was an actual accident two years ago — PTSD criteria now checked formally), and audit substances (nightly wine, which fragments late REM and, when skipped, produces REM-rebound nightmares).
Treatment begins with IRT regardless of the trauma question: she writes out the nightmare in daylight, then deliberately rewrites the script — the bus swerves safely; she steps out onto familiar ground — and rehearses the new version through imagery for ten to twenty minutes each afternoon, never at bedtime. Within weeks the intrusive version typically loses frequency and daytime anticipatory dread. Because the nightmares are trauma-anchored and PTSD therapy proceeds in parallel, prazosin is discussed honestly: many patients benefit, the large PACT trial tempered enthusiasm, side-effects are orthostatic — an informed trial with a defined review. What the plan avoids is a standing benzodiazepine, which sedates, deepens avoidance of the trauma work and causes rebound nightmares at every stop attempt.
How the exam frames it
The matching question is the marks: nightmare versus night terror versus REM behaviour disorder, discriminated by time of night, memory for the event and morning orientation — nightmares late with full recall, terrors early with amnesia and confusion, RBD enacted with injury. The IRT description appears verbatim as "rescripting and rehearsal" among decoys like relaxation training and sleep hygiene. The REM-rebound mechanism (withdrawal of alcohol or antidepressants) is a one-liner, and the PTSD-prazosin link, stated with its mixed evidence, is the pharmacotherapy answer examiners expect.
Frequently asked questions
At what time of night do nightmares typically occur?
In the second half of the night, when REM sleep predominates — and the patient wakes fully oriented with vivid recall of the dream.
How does nightmare disorder differ from sleep terrors?
Terrors arise from deep NREM sleep in the first third of the night with screaming, autonomic surge, confusion and amnesia for the episode, whereas nightmares are dysphoric REM dreams remembered in detail.
What is imagery rehearsal therapy?
The first-line psychological treatment in which the patient rewrites the nightmare's script (especially its ending) and mentally rehearses the new version daily for 10-20 minutes, reducing both nightmare frequency and distress.
Which drug is used for trauma-related nightmares, and with what caveat?
Prazosin, started at 1 mg at night and titrated upward; evidence is mixed — strong earlier studies, a negative large 2018 randomised trial — so it is presented as a monitored trial option.
Which medications can cause nightmares as a side-effect or on withdrawal?
Withdrawal of REM-suppressing agents — alcohol, antidepressants, beta-blockers — through REM rebound, plus dopaminergic drugs; sleep apnoea is an important cause to exclude.